The U.S. Food and Drug Administration (FDA) is making efforts to modernize both the 510(k) approval process for medical devices and study designs for drugs and biologics.
FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The FDA is announcing the opportunity for a limited number of sponsors to participate in a pilot program allowing for more frequent communication with FDA staff to provide a mechanism for addressing late-phase product development issues.
Now that the budget debate has shifted to the appropriatingcommittees of Congress, the President must hold the line on hisgoal of retargeting the funds of programs such as COPS whoseeffectiveness has not been proven or that have been demonstrablyineffective.